Advocacy toolkit launched to halt the 'runaway train' of cancer in Africa

September 6, 2012

Cancer kills more than seven million people a year throughout the world. This is more than HIV/AIDS, tuberculosis and malaria combined, and African countries, which carry a large part of the burden, are the least able of all developing countries to cope with the challenges it presents, says a consortium of international cancer organizations.

In order to try to create a better recognition of the rising burden of cancer in Africa where it is most needed –in Africa– a 'toolkit' for local cancer advocates will be launched Saturday, 15 September at a conference organized by the Africa Oxford Cancer Foundation (AfrOx) and collaborators: Cancer in Africa—Building Transnational Research Collaborations. The toolkit has been produced by AfrOx, together with the African Organisation for Research and Training in Cancer (AORTIC), the European Society for Medical Oncology (ESMO) and the Union for International (UICC). The objective is to encourage cancer advocates to become vocal at the political level, pushing for improvements in cancer health promotion, early detection, treatment and care in Africa by raising awareness among government leaders, opinion makers, health policymakers and the general public, in order that sustainable and affordable measures to tackle cancer can be put in place.

"Many African languages do not even have a word for cancer, and it is commonly perceived to be a disease of the wealthier parts of the world", says Prof David Kerr, University of Oxford, an AfrOx trustee and former President of ESMO. "This is reflected in the lack of screening programs, for example. And although one-third of all cancer deaths are due to preventable causes such as tobacco, alcohol, obesity, and , if there are no public education programs, little can be done in the way of prevention. We hope that the toolkit will provide local advocates with the means to draw the attention of decision-makers to policy level solutions to this disturbing situation, which has such a devastating effect on individuals and families as well as national economies."

Without an advocacy plan to unite the advocate voice, the toolkit promoters say, the chances of change for the better in the provision of cancer services in Africa in the face of competing priorities are slim. What is needed is focused pressure from cancer groups –professional, patients— and concerned individuals —on evidence-based measures that have been proven in Africa to make sure that those who are able to make decisions in favor of better policies and cancer plans actually do so.

"First of all, this means ensuring that decision makers are aware of the problem", says Dr. Adamos Adamou, chair of the ESMO Developing Countries Task Force. "It is bad enough already, but by 2020 the World Health Organization predicts that there will be 16 million new cases of cancer every year, and that 70% of these will be in developing countries. The developing world will suffer the heaviest burden, with 8.8 million cases, over 1.1 million of which will be in sub-Saharan Africa. This is a runaway train coming down the track, and we have to do something to stop it before it is too late."

"It's a big problem, but we think that there are grounds for optimism", says Prof Folakemi Odedina, the AORTIC North America Vice President. "With cohesive and concerted action, cancer in Africa can be tackled and advocacy will play a key role in doing this." The first step is for advocates to define the scale of the problem in their country and to identify individuals and organizations who can influence policy. The toolkit provides guidance for those starting out with sections on working with decision makers and influencers, the development of national cancer plans, working with the media, involving patients in the development of research programs and collaborations, and fundraising.

The advocacy case studies referred to cover fields such as tobacco control, raising awareness of cancer screening and of childhood cancers, the importance of nutrition in preventing cancer and the availability of palliative care. The toolkit will be available on the websites of AfrOx, ESMO, AORTIC and UICC, and sent to ESMO members in Africa and members of AORTIC's African Cancer Advocates Consortium. At the ESMO 2012 Congress in Vienna (28 September-2 October 2012), which is attended by over 15,000 oncologists, the toolkit will be promoted and hard copies available for attendees. The AORTIC 2013 International Cancer Conference: "Cancer in Africa: Bridging Science and Humanity" (21 November 2013, Durban, South Africa) provides a great opportunity for wide distribution and bringing advocates together. A master training program based on the toolkit will be organized by AORTIC and will train 25 advocates to transfer knowledge about cancer advocacy throughout Africa.

"Africa's cancer survival rates are often less than half of those of more developed countries, with many people dying undiagnosed. Many countries do not have a single cancer specialist or a dedicated cancer center for the whole population. For example, only 21 of the 53 African nations have access to radiotherapy. These stark facts bring home the need for urgent action on the policy front and strengthening of the health system services. We have all seen the positive effects of advocacy in Europe and the US, and we hope that the toolkit will empower African advocates to achieve equally impressive results in their countries", says Prof Mary Gospodarowicz, UICC President.

Explore further: World Cancer Day points to prevention

More information: The toolkit is available here: www.esmo.org/fileadmin/media/p … olkit_for_Africa.pdf

Related Stories

World Cancer Day points to prevention

February 3, 2012
Health care organizations from around the globe will come together on Saturday, Feb. 4 to promote cancer prevention as part of this year's World Cancer Day.

Canada should play a role in addressing the global cancer epidemic: researchers

April 10, 2012
Cancer is a growing health concern in low- and middle-income countries, and there is an opportunity for Canada to make a significant contribution to help tackle the disease, states an analysis in CMAJ (Canadian Medical Association ...

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.